# US 2003/0228280 A1 · System for production of helper dependent adenovirus vectors based on use of endonucleases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228280 A1
- Document ID: US20030228280A1
- Status: Published application
- Kind: A1
- Application number: 10/355,330
- Filed: 2003-01-31
- Published: 2003-12-11
- Earliest claimed: 1993-06-24
- Assignees: AdVec, Inc.
- Inventors: Frank L. Graham; Philip Ng; Robin Parks; Silvia Bacchetti; Mauro Anglana
- Web page: https://patentgrep.com/patent/US20030228280A1

## CPC

- C12N 15/86: Viral vectors
- C12N 15/85: for animal cells
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C12N 2710/10343: viral genome or elements thereof as genetic vector
- C12N 2710/10351: Methods of production or purification of viral material
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N 2830/38: being a stuffer
- C12N 2830/42: being an intron or intervening sequence for splicing and/or stability of RNA
- C12N 2840/203: having an IRES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to methods for efficient and reliable construction of adenovirus vectors which contain and express foreign DNA and are useful for gene transfer into mammalian cells, for vaccines and for gene therapy. The invention provides for the growth and purification of adenovirus vectors (helper dependent vectors or HDVs) from which all or most of the viral genes have been removed. The vector system described herein is a new method designed to eliminate helper viruses from the final HDV preparation by cleavage of the helper virus DNA with an endonuclease, alone or in combination with other methods known to limit the level of helper virus contamination of helper dependent vector preparations. The disclosed methods and compositions also provide for regulated control of gene expression.

## Claims

### Claim 1

A helper adenovirus nucleic acid sequence comprising a packaging signal, an inserted endonuclease recognition site, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR), wherein:
(a) said endonuclease recognition site is for an endonuclease that does not cleave anywhere in adenovirus wild-type genome, and wherein said endonuclease recognition site is disposed at a location in said helper adenovirus nucleic acid sequence 3′ to said packaging signal; and
(b) wherein said embedded ITR is disposed at a location in said helper adenovirus nucleic acid sequence 3′ to said endonuclease recognition site.

### Claim 2

A helper adenovirus nucleic acid sequence comprising a packaging signal, an endonuclease recognition site, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR), wherein:
(a) said endonuclease recognition site is for an endonuclease that does not cleave anywhere else in the helper adenovirus nucleic acid sequence, and wherein said endonuclease recognition site is disposed at a location in said helper adenovirus nucleic acid sequence 3′ to said packaging signal;
(b) said embedded ITR is disposed at a location in said adenovirus 3′ to said endonuclease recognition site; and
(c) said packaging signal is flanked on either side thereof by recognition sites for a recombinase, such that upon contact of said helper adenovirus nucleic acid sequence with said recombinase, said packaging signal is excised.

### Claim 3 (depends on 2)

The helper adenovirus nucleic acid sequence according to claim 2 wherein said recognition site for a recombinase is a loxP site, and said recombinase is Cre, or wherein said recognition site for a recombinase is a FRT site, and said recombinase is FLP.

### Claim 4 (depends on 2)

The helper adenovirus nucleic acid sequence according to claim 2 wherein said endonuclease recognition site is flanked on either side thereof by recognition sites for a recombinase, such that upon contact of said helper adenovirus nucleic acid sequence with said recombinase, said endonuclease recognition site is excised.

### Claim 5 (depends on 4)

The helper adenovirus nucleic acid sequence according to claim 4 wherein said recognition sites for a recombinase are loxP sites, and said recombinase is Cre, or wherein said recognition sites for a recombinase are FRT sites, and said recombinase is FLP.

### Claim 6 (depends on 2)

The adenovirus according to claim 2 wherein said packaging signal and said endonuclease recognition site are flanked by recognition sites for a recombinase, such that upon contact of said helper adenovirus nucleic acid sequence with said recombinase, said packaging signal and said endonuclease recognition site are excised.

### Claim 7 (depends on 6)

The helper adenovirus nucleic acid sequence according to claim 6 wherein said recombinase recognition sites are loxP recognition sites, and said recombinase is Cre, or wherein said recognition sites for a recombinase are FRT sites, and said recombinase is FLP.

### Claim 8 (depends on 2)

The helper adenovirus nucleic acid sequence according to claim 2 wherein said endonuclease recognition site is for the endonuclease SceI.

### Claim 9 (depends on 2)

The helper adenovirus nucleic acid sequence according to claim 2 further comprising a deletion or modification in a nucleic acid sequence encoding the adenovirus pIX gene product.

### Claim 10

A system for producing a helper dependent adenovirus vector comprising:
(a) a helper adenovirus nucleic acid sequence comprising a packaging signal, an inserted endonuclease recognition site, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR), wherein:
(i) said endonuclease recognition site is for an endonuclease that does not cleave anywhere else in the adenovirus genome, and wherein said endonuclease recognition site is disposed at a location in said helper adenovirus nucleic acid sequence 3′ to said packaging signal; and
(ii) said embedded ITR is disposed at a location in said helper adenovirus nucleic acid sequence 3′ to said endonuclease recognition site; and
(b) a helper dependent adenovirus vector comprising a left adenoviral ITR, a right adenoviral ITR, an adenoviral packaging signal and additional nucleic acid sequences, such that upon co-introduction of said helper dependent adenovirus vector into a cell with said helper adenovirus nucleic acid sequence, said helper dependent adenovirus vector is packaged.

### Claim 11 (depends on 10)

The system according to claim 10 wherein said packaging signal of said helper adenovirus nucleic acid sequence is flanked on either side by a recombinase recognition site.

### Claim 12 (depends on 11)

The system according to claim 11 wherein said recombinase recognition sites are loxP recognition sites, and said recombinase is Cre, or wherein said recognition site for a recombinase is a FRT site, and said recombinase is FLP.

### Claim 13 (depends on 11)

The system according to claim 11 further comprising a cell which expresses said endonuclease which cleaves said endonuclease recognition site.

### Claim 14 (depends on 12)

The system according to claim 12 further comprising a cell which expresses said Cre and said endonuclease which cleaves said endonuclease recognition site.

### Claim 15 (depends on 11)

The system according to claim 11 further comprising a cell which expresses the adenoviral gene product encoded by adenoviral E1.

### Claim 16 (depends on 11)

The system according to claim 11 wherein said helper adenovirus nucleic acid sequence comprises a deletion or mutation in a sequence encoding the adenovirus pIX gene product, rendering the nucleic acid sequence unable to produce a functional pIX gene product to, thereby inhibiting packaging adenoviral DNA larger than approximately 35 kb.

### Claim 17 (depends on 16)

The system according to claim 16 further comprising a cell which expresses said adenovirus pix gene product.

### Claim 18

A method for making a helper dependent adenovirus vector preparation which comprises:
(A) making a helper adenovirus having a genome comprising an endonuclease recognition site inserted 3′ to an adenoviral packaging signal, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR) disposed 3′ to said endonuclease recognition site, and having said genome incapable of being packaged into an infectious adenoviral virion, due to deletion of the adenoviral packaging signal by endonuclease-mediated cleavage, alone or in combination with (a) site-directed recombinatorial excision of said packaging signal; or (b) a deletion or mutation of adenoviral pIX encoding sequences, whereby a size restricted limitation of genome packaging prevents packaging or a genome which exceeds approximately 35 kb; or both (a) and (b); and
(B) propagating said helper dependent adenovirus vector in the presence of said helper adenovirus of (A) in a cell permissive for replication of said helper dependent adenovirus vector.

### Claim 19 (depends on 18)

The method according to claim 18 wherein said step for making said helper dependent adenovirus vector comprises co-introducing said helper dependent adenoviral vector and said helper adenovirus into a cell, wherein said cell expresses an endonuclease which induces endonuclease-mediated cleavage of the adenoviral packaging signal from said helper adenovirus.

### Claim 20 (depends on 19)

The method according to claim 19 wherein said cell further expresses a recombinase which induces site-directed recombinatorial excision of said packaging signal.

### Claim 21 (depends on 18)

The method according to claim 18 additionally comprising propagating said helper adenovirus, said helper adenovirus nucleic acid sequence comprising a deletion or mutation in a pIX encoding nucleic acid sequence rendering the helper adenovirus nucleic acid sequence unable to produce a functional pIX gene product, such that reduced functional pIX protein levels are produced by said helper adenovirus in cells expressing adenoviral pIX.

### Claim 22 (depends on 18)

The method according to claim 18 further comprising co-introducing said helper dependent adenoviral vector and said helper virus into a cell which does not express adenoviral pIX.

### Claim 23

A method for achieving gene expression in a cell which comprises introducing into said cell an adenoviral vector preparation substantially free of helper adenovirus, wherein said adenoviral vector preparation is produced by a method which comprises:
(A) making a helper adenovirus having a genome comprising an endonuclease recognition site inserted 3′ to an adenoviral packaging signal, a first inverted terminal repeat (ITR) located at one end of, and a second ITR located at the other end of, the nucleic acid sequence, and an embedded inverted terminal repeat (ITR) disposed 3′ to said endonuclease recognition site, and having said genome incapable of being packaged into an infections adenoviral virion, due to deletion of adenoviral packaging signal by endonuclease-mediated cleavage, alone or in combination with (a) site-directed recombinatorial excision of said packaging signal; or (b) deletion or mutation of adenoviral pIX encoding sequences, or both (a) and (b); and
(B) propagating said helper dependent adenovirus vector in the presence of said helper adenovirus of (A) in a cell permissive for replication of said helper dependent adenovirus vector by virtue of introduction into said cell of said helper adenovirus.
